Moderna completes enrollment in large COVID-19 vaccine study

00:17 Sat, 06 March

GEO

USD

$ 3.3202

EUR

€ 3.9640

GBP

£ 4.5835

RUB

₽ 0.0445

TRY

₺ 0.0044

AZN

₼ 0.0195

Bitcoin

49,303.4000

Ethereum

1,533.7200

Bitchoin Cash

499.3020

Litecoin

180.3790

XRP

0.4630

22.Oct .2020 22:00

Moderna completes enrollment in large COVID-19 vaccine study

118

Back

Moderna Inc said it had completed the enrollment of 30,000 participants in a late-stage study testing its experimental coronavirus vaccine, with over a third of the participants from communities of color – Reuters reports.

Over 25,650 participants have so far received their second shot of the vaccine candidate, mRNA-1273 – Reuters quotes the company.

The U.S. Food and Drug Administration requires at least two months of safety data after a full vaccination regime to review applications for emergency use authorization of an experimental vaccine.

Modern Medical Solution